1. Pink Sheet
  2. >>Compliance

US FDA Sets Post-Pandemic Expectations For Manufacturer Remote Interactive Evaluations

 
• By Bowman Cox

Draft guidance outlines how the agency will use RIEs as COVID-19 becomes endemic and agency staff are generally able to travel for site inspections – and how manufacturing facilities should prepare for them.

Pharmaceutical manufacturing operations
when the fda will swoop in remotely • Source: Shutterstock

Draft guidance the US Food and Drug Administration issued 25 October outlines how and why pharmaceutical companies should prepare to accept requests to host remote interactive evaluations at their manufacturing facilities.

Such evaluations by the FDA and other regulatory agencies, which can include screensharing and video walk-throughs, became popular during the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance

Novo, Lilly Ad Challenges Cause Discontinued Claims For Compounded GLP-1s

 
• By Sue Sutter

Two pharmacies, a medical spa and a telehealth company voluntarily removed efficacy, safety and quality claims for compounded GLP-1 products after innovator companies filed challenges with the National Advertising Division.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By Ewan Townsend

If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.